Modulation of complement activity by Nocardia lysozyme digest (NLD)

International Journal of Immunopathology and Pharmacology

Volumn 9, Issue 3, 1996, Pages 113-117

  Ivanovska, N ^a   Neychev, H ^a   Georgieva, P ^a   Barot Ciorbaru, R ^b  

^a INSTITUTE OF MICROBIOLOGY   (Bulgaria)

^b CNRS   (France)

Author keywords

complement activation; mouse AP; NLD

Indexed keywords

ADJUVANT; COMPLEMENT COMPONENT C3; IMMUNOSTIMULATING AGENT; NOCARDIA LYSOZYME DIGEST; SNAKE VENOM; UNCLASSIFIED DRUG; ZYMOSAN;

ANIMAL EXPERIMENT; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; IMMUNOMODULATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SERUM;

EID: 0030463093     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Liszewski, M.K., and J.P. Atkinson. 1993. The complement system. In: Fundamental Immunology. E.W. Paul, ed. Raven Press Ltd. p. 933
2. Frank, M.M., and F.L. Fries. 1991. The role of complement in inflammation and phagocytosis. Immunol. Today 12:322.
3. Motiff, M.C., and M.M. Frank. 1994. Complement resistance in microbes. Springer Semin Immunopathol. 15:327.
4. Bradfield, J.W.B., R.L. Sonhami, and I.E. Addison. 1974. The mechanism of the adjuvant effect of dextran sulfate. Immunology 26:383.
5. Snippe, H., M.J. De Reuver, F. Strickland, J.M.N. Willers, and R.L. Hunter. 1981. Adjuvant effect of noionic block polymer surfactants in humoral anf cellular immunity. Int. Archs. Allergy Appl. Immunol. 65:390.
6. Klerx, J.P.A.M., C.J. Beukelman, H. Van Dijk, and J.M.N. Willers. 1986. Effects of immunological adjuvants on the mouse complement system II. Anti-complementary effects of surface-active compounds. Int. J. Immunopharmacol. 8:47.
7. Barot-Ciorbaru, R., J. Wietzerbin, J.F. Petit, L. Chedid, E. Falcoff, and E. Lederer. 1978. Induction of interferon synthesis in mice by fractions from Nocardia. Infect. Immun. 19:353.
8. Barot-Ciorbaru, R., T. Boscheti, and Petit J.F. 1984. Secretion par de macrophages peritoneaux stimules par les parois de Nocardia opaca de plusieurs facteurs mitogenes pour les thymocytes murins. CR. Acad. Sc. Paris, 298, III 17:483.
9. Barot-Ciorbaru, R., I. Cornil, T. Grand-Perret, and M.F. Pupon. 1987. Antimetastatic effect of immunomodulators from Nocardia opaca in mice and rats: activation of peritoneal macrophages by these fractions. Cancer Immunol. Immunother. 25:111.
10. Barot-Ciorbaru, R., T.J. Linna, J. Altman, and C. Carnaud. 1989. Enhancement of natural killer cell activity by Nocardia opaca fractions. Scand. J. Immunol. 29:133.
11. Mege, J.L., M.V. Sanguedolce, T. Jacob, P. Bongrand, C. Capo, E.B. Myssiakine, and R. Barot-Ciorbaru. 1993. Nocardia fractions, NLD and NWSM, induce tumor necrosis factor-alpha secretion in human monocytes: role of protein-kinase C. Eur. J. Immunol. 23:1582.
12. Barot-Ciorbaru, R. Immunomodulation by bacterial fractions. Int. J. Immunopharmacol. 5/6:469.
13. Trebichavsky, I., R. Barot-Ciorbaru, B. Charley, and I. Splichal. 1994. Induction of inflammatory cytokines by Nocardia fractions. Folia biol. 39:243.
14. Barot-Ciorbaru, R., J. Brochier, T. Miyawaki, J.-L. Preud'Homme, J.-F. Petit, C. Bona, N. Tanigushi, and J.-P. Revillard. Stimulation of human B lymphocytes by Nocardia-delipidated cell mitogen and derived fractions rom N. opaca. structure activity relationship. J. Immunol. 135:3277.
15. Klerx, J.P.A.M., C.J. Beuklman, H. van Dijk, and J.M.N. Willers. 1983. Microassay for colorimetric estimation of complement activity in guinea pig, human and mouse serum. J. Immunol. Meth. 63:215.
16. Klerx, J.P.M., C.J. Beukelman, H. van Dijk, F.J. van Overveld, W.J. van der Maaden, and J.M.N. Willers. 1985. Increased local complement levels upon itraperitoneal injection of mice with Listeria monocytogenes and regulation by polyanions. Infect. Immun. 49:841.
17. Ciorbaru, R., A. Adam, J.F. Petit, E. Lederer, C. Bona, and L. Cheid. 1975. Isolation of mitogenic and adjuvant active fractions from various species of Nocardiae. Infect. Immun. 11:257.
18. Ballow, M., and C.G. Cohrane. 1969. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them. J. Immunol. 103:944.
19. Von Zabern, I., H. Przyklenk, B. Damereau, and B. Zimmermann. 1981. Isolation and properties of a complement inhibitor from Naja haje venom, distinct from known anticomplementary factors in cobra venom. Scand. J. Immunol. 14:109.
20. Edens, E.R., R.J. Linhardt, C.S. Bell, and J.M. Weiler. 1994. Heparin and derivatized heparin inhibit zymosan and cobra venom factor activation of complement in serum. Immunopharmacol. 27:145.